Wegovy (semaglutide) 1.7mg
Wegovy (semaglutide) 1.7mg
Ships From 🇨🇳 China, 12-15 Business Days.
Note: Separate shipping fee per warehouse.
Wegovy® (Semaglutide) 1.7 mg is a prescription medication containing semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist. Developed by Novo Nordisk, Wegovy is indicated for chronic weight management in adults and eligible adolescents with obesity or overweight, in combination with a reduced-calorie diet and increased physical activity, in accordance with approved local prescribing information.
The 1.7 mg strength is typically used as part of the recommended dose-escalation schedule following the 1 mg dose. Depending on the patient's treatment plan and clinical response, it may serve as a dose-escalation step or as a maintenance dose under the supervision of a qualified healthcare provider.
Benefits
- GLP-1 receptor agonist
- Once-weekly subcutaneous administration
- Dose-escalation or maintenance strength, as clinically appropriate
- Supports long-term weight management when combined with diet and exercise
- Convenient carton containing 1 prefilled single-dose injection pen
- Manufactured to strict pharmaceutical quality standards
Common Clinical Use
- Chronic weight management
- Dose escalation following the 1 mg dose
- Maintenance therapy, when clinically appropriate
- Physician-supervised obesity management
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Wegovy® (Semaglutide) |
| Strength | 1.7 mg/0.75 mL |
| Packaging | 1 Prefilled Single-Dose Injection Pen |
| Dosage Form | Solution for Injection |
| Route of Administration | Subcutaneous Injection |
| Active Ingredient | Semaglutide |
| Manufacturer | Novo Nordisk |
Storage
Store refrigerated at 2°C–8°C. Do not freeze. Keep the pen in its original carton to protect it from light. Follow the manufacturer's recommendations regarding room-temperature storage before use.
Important Information
Prescription medicine.
Wegovy must be used only under the supervision of a qualified healthcare professional and in accordance with the approved prescribing information in your country. Read the accompanying patient information leaflet before use. Keep out of reach of children.